重组鸭肠炎病毒载体疫苗研究进展

doi:10.11843/j.issn.0366-6964.2017.11.002

Abstract

Abstract:

Recombinant virus-vectored vaccine is a newly developed vaccine based on viral vectors delivering protective antigens of other pathogens. It can infect host cells and deliver antigen protein encoded by exogenous genes, stimulating both humoral and cellular immune responses. Duck enteritis virus (DEV) has a large genome about 160 kb in length, containing large amounts of non-encoding region and nonessential replication region. Recombinant genetic engineering techniques have brought forward a leap in molecular biology study of DEV and designing DEV-vectored vaccines. Recent studies have demonstrated that DEV may be a promising viral vector candidate and plays a crucial role in future vaccine development. In this review, we summarized the advances of studies on recombinant DEV-vectored vaccines to provide some valuable fundamental information for future DEV vaccine development.

CLC Number:

S852.659.1

MA Yun-chao, CHENG An-chun, WANG Ming-shu, WU Ying. Progress of Recombinant Duck Enteritis Virus-vectored Vaccines[J]. ACTA VETERINARIA ET ZOOTECHNICA SINICA, 2017, 48(11): 2015-2022.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://www.xmsyxb.com/EN/10.11843/j.issn.0366-6964.2017.11.002

https://www.xmsyxb.com/EN/Y2017/V48/I11/2015

References

[1] NUNNALLY B K, TURULA V E, SITRIN R D. Vaccine analysis:strategies, principles, and control[M]. Berlin Heidelberg:Springer-Verlag, 2015:1-80.
[2] ADA G. Overview of vaccines and vaccination[J]. Mol Biotechnol, 2005, 29(3):255-271.
[3] PLOTKIN S A. Vaccines:the fourth century[J]. Clin Vaccine Immunol, 2009, 16(12):1709-1719.
[4] DE GROOT A S, EINCK L, MOISE L, et al. Making vaccines "on demand":a potential solution for emerging pathogens and biodefense?[J]. Hum Vaccines Immunother, 2013, 9(9):1877-1884.
[5] NGCOBO N J, CAMERON N A. The decision making process on new vaccines introduction in South Africa[J]. Vaccine, 2012, 30(3):C9-C13.
[6] PULENDRAN B, AHMED R. Immunological mechanisms of vaccination[J]. Nat Immunol, 2011, 12(6):509-517.
[7] PETROVSKY N. Editorial (thematic issue:the coming of age of DNA vaccines)[J]. Curr Gene Ther, 2014, 14(3):147-148.
[8] SOUZA A P D, HAUT L, REYES-SANDOVAL A, et al. Recombinant viruses as vaccines against viral diseases[J]. Braz J Med Biol Res, 2005, 38(4):509-522.
[9] PLOTKIN S A, PLOTKIN S L. The development of vaccines:how the past led to the future[J]. Nat Rev Microbiol, 2011, 9(12):889-893.
[10] DUAN Z Q, XU H Q, JI X Q, et al. Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases[J]. Future Microbiol, 2015, 10(8):1307-1323.
[11] EWER K J, LAMBE T, ROLLIER C S, et al. Viral vectors as vaccine platforms:from immunogenicity to impact[J]. Curr Opin Immunol, 2016, 41:47-54.
[12] PANICALI D, DAVIS S W, WEINBERG R L, et al. Construction of live vaccines by using genetically engineered poxviruses:biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin[J]. Proc Natl Acad Sci U S A, 1983, 80(17):5364-5368.
[13] WARDEN C, TANG Q Y, ZHU H. Herpesvirus BACs:past, present, and future[J]. J Biomed Biotechnol, 2011, 2011:124595.
[14] KING A M Q, ADAMS M J, CARSTENS E B, et al. Virus taxonomy:ninth report of the international committee on taxonomy of viruses[M]. Oxford:Elsevier, 2012:1221-1234.
[15] LI Y F, HUANG B, MA X L, et al. Molecular characterization of the genome of duck enteritis virus[J]. Virology, 2009, 391(2):151-161.
[16] WU Y, CHENG A C, WANG M S, et al. Complete genomic sequence of Chinese virulent duck enteritis virus[J]. J Virol, 2012, 86(10):5965.
[17] DHAMA K, KUMAR N, SAMINATHAN M, et al. Duck virus enteritis (duck plague)-a comprehensive update[J]. Vet Q, 2017, 37(1):57-80.
[18] WU Y, LI Y G, WANG M S, et al. Preliminary study of the UL55 gene based on infectious Chinese virulent duck enteritis virus bacterial artificial chromosome clone[J]. Virol J, 2017, 14:78.
[19] WAGNER M, RUZSICS Z, KOSZINOWSKI U H. Herpesvirus genetics has come of age[J]. Trends Microbiol, 2002, 10(7):318-324.
[20] LAI C, FISCHER T, MUNROE E. Homologous recombination using bacterial artificial chromosomes[J]. Cold Spring Harb Protoc, 2015, 2015(2):180-190.
[21] YANG J J, SUN B B, HUANG H, et al. High-efficiency scarless genetic modification in Escherichia coli by using lambda red recombination and I-SceI cleavage[J]. Appl Environ Microbiol, 2014, 80(13):3826-3834.
[22] TISCHER B K, KAUFER B B. Viral bacterial artificial chromosomes:generation, mutagenesis, and removal of mini-F sequences[J]. J Biomed Biotechnol, 2012, 2012:472537.
[23] LI H X, WANG Y L, HAN Z X, et al. Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens[J]. Antiviral Res, 2016, 130:19-26.
[24] LIU X M, WEI S S, LIU Y, et al. Recombinant duck enteritis virus expressing the HA gene from goose H5 subtype avian influenza virus[J]. Vaccine, 2013, 31(50):5953-5959.
[25] PERELYGINA L, PATRUSHEVA I, VASIREDDI M, et al. B virus (Macacine herpesvirus 1) glycoprotein D is functional but dispensable for virus entry into macaque and human skin cells[J]. J Virol, 2015, 89(10):5515-5524.
[26] SUN Y, YANG C H, LI J P, et al. Construction of a recombinant duck enteritis virus vaccine expressing hemagglutinin of H9N2 avian influenza virus and evaluation of its efficacy in ducks[J]. Arch Virol, 2017, 162(1):171-179.
[27] LIU J X, CHEN P C, JIANG Y P, et al. A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks[J]. J Virol, 2011, 85(21):10989-10998.
[28] LIU J X, CHEN P C, JIANG Y P, et al. Recombinant duck enteritis virus works as a single-dose vaccine in broilers providing rapid protection against H5N1 influenza infection[J]. Antiviral Res, 2013, 97(3):329-333.
[29] CHEN P C, LIU J X, JIANG Y P, et al. The vaccine efficacy of recombinant duck enteritis virus expressing secreted E with or without PrM proteins of duck Tembusu virus[J]. Vaccine, 2014, 32(41):5271-5277.
[30] MESSERLE M, CRNKOVIC I, HAMMERSCHMIDT W, et al. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome[J]. Proc Natl Acad Sci U S A, 1997, 94(26):14759-14763.
[31] SHIZUYA H, BIRREN B, KIM U J, et al. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector[J]. Proc Natl Acad Sci U S A, 1992, 89(18):8794-8797.
[32] CHEN L, YU B, HUA J G, et al. Construction of a full-length infectious bacterial artificial chromosome clone of duck enteritis virus vaccine strain[J]. Virol J, 2013, 10(1):328.
[33] TISCHER B K, VON EINEM J, KAUFER B, et al. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli[J]. Biotechniques, 2006, 40(2):191-197.
[34] TISCHER B K, SMITH G A, OSTERRIEDER N. En passant mutagenesis:a two step markerless red recombination system[M]//BRAMAN J. In Vitro Mutagenesis Protocols. 3rd ed. Totowa, NJ:Humana Press, 2010:421-430.
[35] LI M Z, ELLEDGE S J. MAGIC, an in vivo genetic method for the rapid construction of recombinant DNA molecules[J]. Nat Genet, 2005, 37(3):311-319.
[36] TOBLER K, FRAEFEL C. Infectious delivery of alphaherpesvirus bacterial artificial chromosomes[M]//NARAYANAN K. Bacterial Artificial Chromosomes. New York, NY:Humana Press, 2015, 217-230.
[37] COPELAND N G, JENKINS N A, COURT D L. Recombineering:a powerful new tool for mouse functional genomics[J]. Nat Rev Genet, 2001, 2(10):769-779.
[38] YU D G, ELLIS H M, LEE E C, et al. An efficient recombination system for chromosome engineering in Escherichia coli[J]. Proc Natl Acad Sci U S A, 2000, 97(11):5978-5983.
[39] DATSENKO K A, WANNER B L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products[J]. Proc Natl Acad Sci U S A, 2000, 97(12):6640-6645.
[40] 刘陆罡, 纪晓俊, 沈梦秋, 等. 大肠杆菌无痕重组的策略与应用[J]. 中国生物工程杂志, 2014, 34(8):88-96.
LIU L G, JI X J, SHEN M Q, et al. Red-mediated scarless recombination:strategies and applications[J]. China Biotechnology, 2014, 34(8):88-96. (in Chinese)
[41] YOON Y G, CHO J H, KIM S C. Cre/loxP-mediated excision and amplification of large segments of the Escherichia coli genome[J]. Genet Anal:Biomol Eng, 1998, 14(3):89-95.
[42] OUEDRAOGO J P, ARENTSHORST M, NIKOLAEV I, et al. I-SceI-mediated double-strand DNA breaks stimulate efficient gene targeting in the industrial fungus Trichoderma reesei[J]. Appl Microbiol Biotechnol, 2015, 99(23):10083-10095.
[43] ARAZOE T, YOUNOMARU T, OHSATO S, et al. Site-specific DNA double-strand break generated by I-SceI endonuclease enhances ectopic homologous recombination in Pyricularia oryzae[J]. FEMS Microbiol Lett, 2014, 352(2):221-229.
[44] TISCHER B K, KAUFER B B, SOMMER M, et al. A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9[J]. J Virol, 2007, 81(23):13200-13208.
[45] WUSSOW F, FICKENSCHER H, TISCHER B K. Red-mediated transposition and final release of the mini-F vector of a cloned infectious herpesvirus genome[J]. PLoS One, 2009, 4(12):e8178.
[46] ROTH S J, HÖPER D, BEER M, et al. Recovery of infectious virus from full-length cowpox virus (CPXV) DNA cloned as a bacterial artificial chromosome (BAC)[J]. Vet Res, 2011, 42:3.
[47] WANG J C, OSTERRIEDER N. Generation of an infectious clone of duck enteritis virus (DEV) and of a vectored DEV expressing hemagglutinin of H5N1 avian influenza virus[J]. Virus Res, 2011, 159(1):23-31.
[48] WANG J C, GE A M, XU M W, et al. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens[J]. Virol J, 2015, 12:126.
[49] ZOU Z, HU Y, LIU Z G, et al. Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection[J]. Vet Res, 2015, 46:42.
[50] ZOU Z, MA J, HUANG K, et al. Live attenuated vaccine based on duck enteritis virus against duck hepatitis a virus types 1 and 3[J]. Front Microbiol, 2016, 7:1613.
[51] ZOU Z, LIU Z G, JIN M L. Efficient strategy to generate a vectored duck enteritis virus delivering envelope of duck Tembusu virus[J]. Viruses, 2014, 6(6):2428-2443.
[52] EL ZOWALATY M E, BUSTIN S A, HUSSEINY M I, et al. Avian influenza:virology, diagnosis and surveillance[J]. Future Microbiol, 2013, 8(9):1209-1227.

Progress of Recombinant Duck Enteritis Virus-vectored Vaccines

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	ZHOU Yang, WU Weizi, CAO Weisheng, WANG Fuguang, XU Xiuqiong, ZHONG Wenxia, WU Liyang, YE Jian, LU Shousheng. A Whole Genome Sequencing Method for African Swine Fever Virus based on Nanopore Sequencing Technology was Established [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(5): 2080-2089.
[2]	DENG Gunan, ZHANG Jiaqi, BAO Zhipeng, CHEN Taoyun, YU Qisheng, DING Lu, ZHU Chenxi, WANG Yi, REN Yupeng, HE Chao, ZHANG Bin. Detection of Feline Herpesvirus Type 1 and Pathogenicity of an Isolated Strain [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(5): 2253-2258.
[3]	LI Yixuan, NIU Jingyi, LI Gang, WAN Chao, FANG Rendong, YE Chao. Research Progress on the Biological Functions of Tegument Proteins Encoded by Pseudorabies Virus [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(3): 957-970.
[4]	YAN Wenqian, HOU Jing, YANG Jinke, HAO Yu, YANG Xing, SHI Xijuan, ZHANG Dajun, BIE Xintian, CHEN Guohui, CHEN Lingling, HE Lu, ZHAO Meiyu, ZHAO Siyue, ZHENG Haixue, ZHANG Keshan. Monoclonal Antibody against D1133 L Protein of African Swine Fever Virus Inhibits Its Replication [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(2): 854-859.
[5]	CHI Lili, WANG Junna, ZHANG Yuming, LIU Jian, CHEN Zhiyuan, LI Shufan, YIN Yanbo, XU Shouzhen. Prokaryotic Expression and Immunogenicity Analysis of Truncated Fusion Protein of FAdV-4 Fiber2 and FAdV-8b Fiber [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(12): 5162-5170.
[6]	LI Linyan, TENG Man, LIU Jinling, ZHENG Luping, CHAI Shujun, DING Ke, YU Zuhua, LUO Jun. Development of a Monoclonal Antibody Pool for Marek’s Disease Virus and Identification of a Specific mAb against the Glycoprotein gB [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(11): 4712-4723.
[7]	ZHANG Fangyuan, YANG Dawei, QIU Deyang, JIANG Guoqian, LI Guimei, SHAN Hu. Expression of ASFV P30 Protein and Development of ASFV Antibody Detection Method Based on x-MAP Technology [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(10): 4300-4310.
[8]	FENG Yongzhi, GONG Ting, WU Dongdong, GAO Qi, ZHENG Xiaoyu, ZHANG Guihong, SUN Yankuo. Analysis of Factors Affecting the Infectivity of African Swine Fever Virus on Cultured Cells [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(8): 3406-3414.
[9]	ZHANG Yi, WANG Chenyan, YANG Xiao, SHAO Guoqing, HOU Bo. Phylogenetic Analysis and Pathogenicity of an Avian Infectious Laryngotracheitis Virus Strain WF03 [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(8): 3435-3444.
[10]	DING Xiaoyan, HE Jiuxiang, ZHOU Xiaoyang, ZHOU Yuxin, LI Jintao. Preliminary Identification of Host Regulatory Genes and Virulence Genes during African Swine Fever Virus Infection [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(7): 2964-2971.
[11]	CHEN Hongjian, CAO Yan, FAN Jie, GAN Rongxuan, SONG Wenbo, YU Shengwei, YANG Ting, ZHAO Yanxia, WEI Chunyan, XIE Rui, HUA Lin, PENG Zhong, WU Bin. Prevalence and Phylogenetic Analysis of Pseudorabies Virus within Pig Slaughterhouses in Hubei Province of China during 2020-2022 [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(7): 2972-2981.
[12]	WANG Jiali, ZHOU Ning, CHEN Xi, YUE Hua, TANG Cheng. Isolation, Identification and Pathogenicity of Canine Adenovirus Type 2 Strain with Natural Deletion in E3 Gene [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(7): 2982-2990.
[13]	FENG Weimin, LIU Xiao, HUANG Teng. The Evasion Strategy against CTL Recognition by Herpesviruses of Domestic Animals: Interference with MHC Class Ⅰ Antigen Presentation Pathway [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(6): 2241-2251.
[14]	GAO Zhenzhen, MENG Zejing, HE Xiaobing, FANG Yongxiang, TIAN Huihui, CHEN Guohua, JING Zhizhong. Identification of Immunogenicity and Neutralizing Activity of Ectromelia Virus EVM135 and EVM085 Proteins [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(6): 2468-2477.
[15]	WANG Ying, ZHU Jiahong, ZHAO Jiakai, JI Pinpin, CHEN Xu, ZHANG Lu, LIU Baoyuan, SUN Yani, ZHAO Qin. Screening and Identification of Nanobodies against NP419L Protein of African Swine Fever Virus and Its Preliminary Application of Antibody Detection [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(6): 2509-2520.